CH576964A5 - - Google Patents

Info

Publication number
CH576964A5
CH576964A5 CH270476A CH270476A CH576964A5 CH 576964 A5 CH576964 A5 CH 576964A5 CH 270476 A CH270476 A CH 270476A CH 270476 A CH270476 A CH 270476A CH 576964 A5 CH576964 A5 CH 576964A5
Authority
CH
Switzerland
Application number
CH270476A
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of CH576964A5 publication Critical patent/CH576964A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH270476A 1972-03-10 1973-03-08 CH576964A5 (xx)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB1125172 1972-03-10
GB3063572 1972-06-30
GB4859372 1972-10-21
GB553173A GB1416872A (en) 1972-03-10 1973-02-05 4-aminoquinoline derivatives

Publications (1)

Publication Number Publication Date
CH576964A5 true CH576964A5 (xx) 1976-06-30

Family

ID=27447454

Family Applications (2)

Application Number Title Priority Date Filing Date
CH343873A CH577476A5 (xx) 1972-03-10 1973-03-08
CH270476A CH576964A5 (xx) 1972-03-10 1973-03-08

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH343873A CH577476A5 (xx) 1972-03-10 1973-03-08

Country Status (10)

Country Link
JP (1) JPS604187B2 (xx)
AU (1) AU467944B2 (xx)
BE (1) BE855713Q (xx)
CH (2) CH577476A5 (xx)
DE (1) DE2311570C2 (xx)
FR (1) FR2181807B1 (xx)
GB (1) GB1416872A (xx)
HK (1) HK10279A (xx)
KE (1) KE2916A (xx)
MY (1) MY7900137A (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA743270B (en) * 1973-06-15 1975-05-28 Upjohn Co Anti-hypertensive compounds
GB1474296A (en) * 1975-01-23 1977-05-18 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
JPS5717907Y2 (xx) * 1977-09-05 1982-04-14
GB1573186A (en) * 1977-09-14 1980-08-20 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
JPS6055170A (ja) * 1983-09-05 1985-03-30 株式会社多川工業 鉄骨切断装置
PH22302A (en) * 1985-02-11 1988-07-22 Fujisawa Pharmaceutical Co Piperidine compounds
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
US5656642A (en) * 1993-04-07 1997-08-12 Otsuka Pharmaceutical Co., Ltd. Peripheral vasodilating agent containing piperidine derivative as active ingredient
US5567718A (en) * 1994-08-11 1996-10-22 Hoechst Marion Roussel Inc. 2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake inhibitors
AUPP818099A0 (en) * 1999-01-14 1999-02-11 Fujisawa Pharmaceutical Co., Ltd. New n-containing heterocyclic compounds
SE0000540D0 (sv) 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
MY142362A (en) 2004-01-29 2010-11-30 Otsuka Pharma Co Ltd Pharmaceutical composition for promoting angiogenesis
WO2007108936A2 (en) 2006-03-15 2007-09-27 Wyeth N-substituted-azacyclylamines as histamine-3 antagonists
CA2649913A1 (en) * 2006-05-19 2007-11-29 Wyeth N-benzoyl- and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
WO2008013130A1 (fr) * 2006-07-28 2008-01-31 Kaneka Corporation Méthode de production d'un composé 3-amino-azoté optiquement actif
PE20081152A1 (es) 2006-10-06 2008-08-10 Wyeth Corp Azaciclilaminas n-sustituidas como antagonistas de histamina-3
US7946311B2 (en) 2007-02-01 2011-05-24 Hobart Brorthers Company Robust preconditioned air hose
CL2008002088A1 (es) 2007-07-16 2008-09-05 Wyeth Corp Compuestos derivados de fenilo sustituido, moduladores del receptor de histamina 3; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de trastornos cognitivos tales como demencia, alzheimer, entre otros.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA731646A (en) * 1962-05-08 1966-04-05 Roussel-Uclaf 4-(2'(.beta.-MORPHOLYLETHOXYCARBONYL) PHENYLAMINE) 7-CHLORO QUINOLEINE ET SES SELS, AINSI QUE LEUR PROCEDE DE PREPARATION
BE754586A (fr) * 1969-08-08 1971-02-08 Upjohn Co Preparations pharmaceutiques a base de p-(4-quinolylamino) benzamide etleur utilisation
BE754587A (fr) * 1969-08-08 1971-02-08 Upjohn Co Nouveaux p-(trihalomethylquinolylamino) benzamides et leur procede de preparation

Also Published As

Publication number Publication date
AU5242173A (en) 1974-10-17
HK10279A (en) 1979-03-09
FR2181807A1 (xx) 1973-12-07
CH577476A5 (xx) 1976-07-15
FR2181807B1 (xx) 1976-10-22
JPS49273A (xx) 1974-01-05
AU467944B2 (en) 1975-12-18
MY7900137A (en) 1979-12-31
BE855713Q (fr) 1977-10-03
DE2311570C2 (de) 1986-03-13
KE2916A (en) 1979-03-30
JPS604187B2 (ja) 1985-02-01
GB1416872A (en) 1975-12-10
DE2311570A1 (de) 1973-09-13

Similar Documents

Publication Publication Date Title
FR2205349A1 (xx)
FR2181807B1 (xx)
CS155031B1 (xx)
FR2195580A1 (xx)
JPS5211824B2 (xx)
JPS49108235A (xx)
JPS4959A (xx)
JPS4917944A (xx)
JPS504626Y2 (xx)
JPS4979915U (xx)
FR2204067A1 (xx)
JPS521574Y2 (xx)
JPS4979489U (xx)
CS155484B1 (xx)
JPS4895549A (xx)
JPS4887474U (xx)
JPS48113348U (xx)
JPS48104123U (xx)
CH562118A5 (xx)
CH569225A5 (xx)
CH563243A5 (xx)
CH562680A5 (xx)
CH586716A5 (xx)
CH561884A5 (xx)
CH564956A5 (xx)

Legal Events

Date Code Title Description
PL Patent ceased